Niki BioSolutions, Inc. Equity Securities, FV-NI
Niki BioSolutions, Inc. (NIKI) had Equity Securities, FV-NI of $4.08 million as of 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:EquitySecuritiesFvNi · last filed 2026-05-11
- 2025-12-31: Equity Securities, FV-NI $4.08M.
- 2024-12-31: Equity Securities, FV-NI $4.08M.
| Period end | Equity Securities, FV-NI |
|---|---|
| 2025-12-31 | $4.08M S-4/A · filed 2026-05-11 |
| 2024-12-31 | $4.08M S-4/A · filed 2026-05-11 |